<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2014-12-18-24</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-682</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АРТЕРИАЛЬНАЯ ГИПЕРТЕНЗИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ARTERIAL HYPERTENSION</subject></subj-group></article-categories><title-group><article-title>Диуретики при лечении больных артериальной гипертензией: результаты сравнительного исследования ДОВЕРИЕ</article-title><trans-title-group xml:lang="en"><trans-title>Diuretics in the treatment of patients with arterial hypertension: results of the DOVERIE comparative study</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шевченко</surname><given-names>О. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Shevchenko</surname><given-names>OP</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аверин</surname><given-names>Е. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Averin</surname><given-names>EE</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Выгодин</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vygodin</surname><given-names>VA</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российский национальный исследовательский медицинский университет им. Н.И. Пирогова, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Государственный научно-исследовательский центр профилактической медицины, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Research Center for Preventive Medicine, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2014</year></pub-date><volume>0</volume><issue>12</issue><fpage>18</fpage><lpage>24</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шевченко О.П., Аверин Е.Е., Выгодин В.А., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Шевченко О.П., Аверин Е.Е., Выгодин В.А.</copyright-holder><copyright-holder xml:lang="en">Shevchenko O., Averin E., Vygodin V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/682">https://www.med-sovet.pro/jour/article/view/682</self-uri><abstract><p>Часто обсуждаются вопросы использования тиазидных, тиазидоподобных и петлевых диуретиков у больных с артериальной гипертензией. Прямых сравнительных исследований диуретиков разных классов при артериальной гипертензии крайне мало. Исследование ДОВЕРИЕ (эффективность и безопасность Диувера в кОмбинироВанной тЕрапии у пациентов с артеРиальной гипертонией в условИях первичного звена здравоохранЕния) было рандомизированным, сравнительным, открытым. По данным исследования выявлено, что антигипертензивный эффект и безопасность лечения торасемида и индапамида существенно не различаются. Добавление торасемида как к монотерапии иАПФ/БРА II, так и при замене гидрохлоротиазида в составе комбинированной терапии иАПФ/БРА II + ГХТЗ приводило к дополнительному достоверному снижению АД, что позволило достичь целевых значений АД у большинства больных. На фоне терапии торасемидом не наблюдалось увеличения ЧСС, не происходило значимых изменений уровня калия, мочевой кислоты и глюкозы.</p></abstract><trans-abstract xml:lang="en"><p>The use of thiazide, thiazide-like and loop diuretics in patients with hypertension is widely discussed. So far, there have been few direct comparative studies of different classes of diuretics in hypertension. The randomized, comparative, open DOVERIE study (efficacy and safety of Diuver in combination therapy in hypertensive patients in outpatient setting) found that the antihypertensive effects and safety of torasemide and indapamide are not significantly different. Adding torasemide either to monotherapy with ACEI/ARB II or as substitute for hydrochlorothiazide in combination therapy with ACEI/ARB II + HCTZ resulted in a further significant decrease in blood pressure and allowed to reach target BP in a majority of patients. Therapy with torasemide was not associated with any increase in heart rate, significant changes in potassium levels, uric acid and glucose.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертония</kwd><kwd>торасемид</kwd><kwd>индапамид</kwd><kwd>гидрохлоротиазид</kwd><kwd>комбинированная терапия</kwd><kwd>hypertension</kwd><kwd>torasemide</kwd><kwd>indapamide</kwd><kwd>hydrochlorothiazide</kwd><kwd>combination therapy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Горбунов В.М., Оганов Р.Г. Торасемид - петлевой диуретик с особыми свойствами. Кардиоваскулярная терапия и проф., 2005, 5 (5).</mixed-citation><mixed-citation xml:lang="en">Горбунов В.М., Оганов Р.Г. Торасемид - петлевой диуретик с особыми свойствами. Кардиоваскулярная терапия и проф., 2005, 5 (5).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Сидоренко Б.А., Преображенский Д.В., Батыралиев ТА. и др. Место диуретиков в лечении хронической сердечной недостаточности. Часть I Кардиология, 2005, 8: 76-83.</mixed-citation><mixed-citation xml:lang="en">Сидоренко Б.А., Преображенский Д.В., Батыралиев ТА. и др. Место диуретиков в лечении хронической сердечной недостаточности. Часть I Кардиология, 2005, 8: 76-83.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Киношенко Е.И. Ковалева Е.А., Нудьга А.Н. и др. Петлевые диуретики и артериальная гипертония. Медицина неотложных состояний, 2011, 7: 98-100.</mixed-citation><mixed-citation xml:lang="en">Киношенко Е.И. Ковалева Е.А., Нудьга А.Н. и др. Петлевые диуретики и артериальная гипертония. Медицина неотложных состояний, 2011, 7: 98-100.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Roca-Cusachs A et al. Clinical Effects of Torasemide Prolonged Release in Mild-to-Moderate Hypertension: A Randomized Noninferiority Trial Versus Torasemide Immediate Release. Cardiovasc Ther., 2008, 26(2): 91-100.</mixed-citation><mixed-citation xml:lang="en">Roca-Cusachs A et al. Clinical Effects of Torasemide Prolonged Release in Mild-to-Moderate Hypertension: A Randomized Noninferiority Trial Versus Torasemide Immediate Release. Cardiovasc Ther., 2008, 26(2): 91-100.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Coca A. Effect of torasemide in monotherapy or associated to other antihypertensive drugs on pulse pressure in essential hypertension. American Journal of Hypertension, 15.</mixed-citation><mixed-citation xml:lang="en">Coca A. Effect of torasemide in monotherapy or associated to other antihypertensive drugs on pulse pressure in essential hypertension. American Journal of Hypertension, 15.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Spannbrucker N, Achhammer I, Metz P, Glocke M. Comparative study on the hypertensive efficacy of torasemide and indapamide in patients with essential hypertention. Drug Res, 1988; 38 (1): 190-193.</mixed-citation><mixed-citation xml:lang="en">Spannbrucker N, Achhammer I, Metz P, Glocke M. Comparative study on the hypertensive efficacy of torasemide and indapamide in patients with essential hypertention. Drug Res, 1988; 38 (1): 190-193.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Neugebauer G, Besenfelder E, van M llendorf E. Pharmacokinetics and metabolism of torasemide in man. Drug Res, 1988, 38(1): 164-166.</mixed-citation><mixed-citation xml:lang="en">Neugebauer G, Besenfelder E, van M llendorf E. Pharmacokinetics and metabolism of torasemide in man. Drug Res, 1988, 38(1): 164-166.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Brater DC, Leinfelder J, Anderson SA. Clinical pharmacology of torasemide, a new loop diuretic. Clin Pharmacol Ther, 1987, 42: 187-192.</mixed-citation><mixed-citation xml:lang="en">Brater DC, Leinfelder J, Anderson SA. Clinical pharmacology of torasemide, a new loop diuretic. Clin Pharmacol Ther, 1987, 42: 187-192.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bоelke T, Achhammer I. Torasemide: review of its pharmacology and therapeutic use. Drugs of today, 1994, 8: 1-28.</mixed-citation><mixed-citation xml:lang="en">Bоelke T, Achhammer I. Torasemide: review of its pharmacology and therapeutic use. Drugs of today, 1994, 8: 1-28.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Reyes AJ. Effects of diuretics on outputs and flows of urine and urinary sodium in healthy subjects. Drugs, 1991, 41(3): 35-39.</mixed-citation><mixed-citation xml:lang="en">Reyes AJ. Effects of diuretics on outputs and flows of urine and urinary sodium in healthy subjects. Drugs, 1991, 41(3): 35-39.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Achhammer I, Metz P. Low dose loop diuretics in essential hypertension: Experience with torasemide. Drugs, 1991, 41(3): 80-91.</mixed-citation><mixed-citation xml:lang="en">Achhammer I, Metz P. Low dose loop diuretics in essential hypertension: Experience with torasemide. Drugs, 1991, 41(3): 80-91.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Porcellati C, Verdecchia P, Schillaci G et al. La torasemide, nuovo diuretico del'ansa, nell trattamento dell'ipertensione arteriosa: Studio controlla to in doppla cecita. BasRazion Terapia, 1990, 20: 407-410.</mixed-citation><mixed-citation xml:lang="en">Porcellati C, Verdecchia P, Schillaci G et al. La torasemide, nuovo diuretico del'ansa, nell trattamento dell'ipertensione arteriosa: Studio controlla to in doppla cecita. BasRazion Terapia, 1990, 20: 407-410.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Baumgart P, Walger P, von Eiff M, Achhammer I. Long-term efficacy and tolerance of torasemide in hypertension. Progress in pharmacology and Clinical Pharmacology, Gustav-Fischer-Verlag: Stuttgart 1990, 8: 169-181.</mixed-citation><mixed-citation xml:lang="en">Baumgart P, Walger P, von Eiff M, Achhammer I. Long-term efficacy and tolerance of torasemide in hypertension. Progress in pharmacology and Clinical Pharmacology, Gustav-Fischer-Verlag: Stuttgart 1990, 8: 169-181.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Spannbrucker N, Achhammer I, Metz P, Glocke M. Comparative study on the hypertensive efficacy of torasemide and indapamide in patients with essential hypertension. Drug Res, 1988, 38(1): 190-193.</mixed-citation><mixed-citation xml:lang="en">Spannbrucker N, Achhammer I, Metz P, Glocke M. Comparative study on the hypertensive efficacy of torasemide and indapamide in patients with essential hypertension. Drug Res, 1988, 38(1): 190-193.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Reyes AJ, Chiesa PD, Santucci MR et al. Hydrochlorothiazide versus a nondiuretic dose of torasemide as once daily antihypertensive monopharmaco-therapy in elderly patients; randomized and double-blind study. Progress in Pharmacology and Clinical Pharmacology, Gustav-Fischer-Verlag: Stuttgart 1990, 8: 183-209.</mixed-citation><mixed-citation xml:lang="en">Reyes AJ, Chiesa PD, Santucci MR et al. Hydrochlorothiazide versus a nondiuretic dose of torasemide as once daily antihypertensive monopharmaco-therapy in elderly patients; randomized and double-blind study. Progress in Pharmacology and Clinical Pharmacology, Gustav-Fischer-Verlag: Stuttgart 1990, 8: 183-209.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Boelke T, Piesche L Influence of 2,5-5 mg torasemide o.d. versus 25-50 mg HCTZ/50-100 triamterene o.d. on serum parameters in elderly patients with mild to moderate hypertension. Diuretics IV: Chemistry, Pharmacology and clinical Applications, Excerpta Medica: Amsterdam 1993, 279-82.</mixed-citation><mixed-citation xml:lang="en">Boelke T, Piesche L Influence of 2,5-5 mg torasemide o.d. versus 25-50 mg HCTZ/50-100 triamterene o.d. on serum parameters in elderly patients with mild to moderate hypertension. Diuretics IV: Chemistry, Pharmacology and clinical Applications, Excerpta Medica: Amsterdam 1993, 279-82.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Achhammer I, Eberhard R Comparison of serum potassium levels during long-term treatment of hypertension patients with 2,5 mg torasemide o.d. or 50 mg triamterene/25 mg hydrochlorothi-azide o.d. Progress in Pharmacology and Clinical Pharmacology, Gustav-Fischer-Verlag: Stuttgart 1990, 8: 211-220.</mixed-citation><mixed-citation xml:lang="en">Achhammer I, Eberhard R Comparison of serum potassium levels during long-term treatment of hypertension patients with 2,5 mg torasemide o.d. or 50 mg triamterene/25 mg hydrochlorothi-azide o.d. Progress in Pharmacology and Clinical Pharmacology, Gustav-Fischer-Verlag: Stuttgart 1990, 8: 211-220.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Baumgart P. Torasemide in comparison with thiazides in the treatment of hypertension. Cardiovasc Drugs Ther., 1993, 7(1): 63-68.</mixed-citation><mixed-citation xml:lang="en">Baumgart P. Torasemide in comparison with thiazides in the treatment of hypertension. Cardiovasc Drugs Ther., 1993, 7(1): 63-68.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Spannbrucker N, Achhammer I, Metz P, Glocke M. Comparative study on the hypertensive efficacy of torasemide and indapamide in patients with essential hypertension. Drug Res, 1988, 38(1): 190-193.</mixed-citation><mixed-citation xml:lang="en">Spannbrucker N, Achhammer I, Metz P, Glocke M. Comparative study on the hypertensive efficacy of torasemide and indapamide in patients with essential hypertension. Drug Res, 1988, 38(1): 190-193.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Reyes AJ, Chiesa PD, Santucci MR et al. Hydrochlorothiazide versus a nondiuretic dose of torasemide as once daily antihypertensive monopharmaco-therapy in elderly patients; randomized and double-blind study. Progress in Pharmacology and Clinical Pharmacology, Gustav-Fischer-Verlag: Stuttgart 1990, 8: 183-209.</mixed-citation><mixed-citation xml:lang="en">Reyes AJ, Chiesa PD, Santucci MR et al. Hydrochlorothiazide versus a nondiuretic dose of torasemide as once daily antihypertensive monopharmaco-therapy in elderly patients; randomized and double-blind study. Progress in Pharmacology and Clinical Pharmacology, Gustav-Fischer-Verlag: Stuttgart 1990, 8: 183-209.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Boelke T, Piesche L Influence of 2,5-5 mg torasemide o.d. versus 25-50 mg HCTZ/50-100 triamterene o.d. on serum parameters in elderly patients with mild to moderate hypertension. Diuretics IV: Chemistry, Pharmacology and clinical Applications, Excerpta Medica: Amsterdam 1993, 279-82.</mixed-citation><mixed-citation xml:lang="en">Boelke T, Piesche L Influence of 2,5-5 mg torasemide o.d. versus 25-50 mg HCTZ/50-100 triamterene o.d. on serum parameters in elderly patients with mild to moderate hypertension. Diuretics IV: Chemistry, Pharmacology and clinical Applications, Excerpta Medica: Amsterdam 1993, 279-82.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Achhammer I, Eberhard R Comparison of serum potassium levels during long-term treatment of hypertension patients with 2,5 mg torasemide o.d. or 50 mg triamterene/25 mg hydrochlorothi-azide o.d. Progress in Pharmacology and Clinical Pharmacology, Gustav-Fischer-Verlag: Stuttgart 1990, 8: 211-220.</mixed-citation><mixed-citation xml:lang="en">Achhammer I, Eberhard R Comparison of serum potassium levels during long-term treatment of hypertension patients with 2,5 mg torasemide o.d. or 50 mg triamterene/25 mg hydrochlorothi-azide o.d. Progress in Pharmacology and Clinical Pharmacology, Gustav-Fischer-Verlag: Stuttgart 1990, 8: 211-220.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Baumgart P. Torasemide in comparison with thiazides in the treatment of hypertension. Cardiovasc Drugs Ther., 1993, 7(1): 63-68.</mixed-citation><mixed-citation xml:lang="en">Baumgart P. Torasemide in comparison with thiazides in the treatment of hypertension. Cardiovasc Drugs Ther., 1993, 7(1): 63-68.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
